Deutsche Bank Ag\ Arcus Biosciences, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 34,223 shares of RCUS stock, worth $528,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,223

Previous 26,666 28.34%

Holding current value

$528,403

Previous $406,000 28.82%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$13.69 - $18.01 $103,455 - $136,101	7,557 Added 28.34%	34,223 $523,000
Q2 2024 Aug 14, 2024	SELL	$14.59 - $18.48 $23,883 - $30,251	-1,637 Reduced 5.78%	26,666 $406,000
Q1 2024 May 15, 2024	BUY	$14.83 - $20.18 $1,275 - $1,735	86 Added 0.3%	28,303 $534,000
Q4 2023 Feb 14, 2024	BUY	$13.43 - $19.63 $18,305 - $26,755	1,363 Added 5.08%	28,217 $538,000
Q3 2023 Nov 09, 2023	BUY	$17.62 - $23.54 $59,555 - $79,565	3,380 Added 14.4%	26,854 $482,000
Q2 2023 Aug 14, 2023	SELL	$16.97 - $22.03 $187,213 - $243,034	-11,032 Reduced 31.97%	23,474 $476,000
Q1 2023 May 15, 2023	SELL	$15.96 - $23.15 $291,222 - $422,418	-18,247 Reduced 34.59%	34,506 $629,000
Q4 2022 Feb 13, 2023	SELL	$19.7 - $35.71 $2.94 Million - $5.34 Million	-149,412 Reduced 73.91%	52,753 $1.09 Million
Q3 2022 Nov 14, 2022	SELL	$23.23 - $30.07 $120,006 - $155,341	-5,166 Reduced 2.49%	202,165 $5.29 Million
Q2 2022 Aug 11, 2022	BUY	$17.23 - $37.73 $106,739 - $233,737	6,195 Added 3.08%	207,331 $5.25 Million
Q1 2022 May 13, 2022	SELL	$28.92 - $41.83 $68,164 - $98,593	-2,357 Reduced 1.16%	201,136 $6.35 Million
Q4 2021 Feb 11, 2022	BUY	$31.38 - $48.47 $31,128 - $48,082	992 Added 0.49%	203,493 $8.24 Million
Q3 2021 Nov 04, 2021	SELL	$26.93 - $37.68 $798,124 - $1.12 Million	-29,637 Reduced 12.77%	202,501 $7.06 Million
Q2 2021 Aug 11, 2021	BUY	$22.75 - $35.77 $2.19 Million - $3.44 Million	96,200 Added 70.77%	232,138 $6.38 Million
Q1 2021 May 13, 2021	BUY	$26.16 - $41.39 $2.63 Million - $4.15 Million	100,345 Added 281.92%	135,938 $3.82 Million
Q4 2020 Feb 16, 2021	BUY	$17.0 - $32.36 $164,849 - $313,794	9,697 Added 37.45%	35,593 $925,000
Q3 2020 Nov 12, 2020	SELL	$17.14 - $25.47 $321,289 - $477,435	-18,745 Reduced 41.99%	25,896 $443,000
Q2 2020 Aug 13, 2020	BUY	$13.97 - $36.56 $357,995 - $936,886	25,626 Added 134.77%	44,641 $1.1 Million
Q1 2020 May 14, 2020	SELL	$8.78 - $19.28 $110,268 - $242,137	-12,559 Reduced 39.78%	19,015 $264,000
Q4 2019 Feb 14, 2020	SELL	$7.33 - $10.79 $127,915 - $188,296	-17,451 Reduced 35.6%	31,574 $318,000
Q3 2019 Nov 14, 2019	BUY	$6.44 - $10.18 $75,708 - $119,676	11,756 Added 31.54%	49,025 $445,000
Q2 2019 Aug 14, 2019	SELL	$7.29 - $13.38 $15,265 - $28,017	-2,094 Reduced 5.32%	37,269 $294,000
Q1 2019 May 15, 2019	SELL	$8.95 - $12.49 $14,525 - $20,271	-1,623 Reduced 3.96%	39,363 $490,000
Q4 2018 Feb 14, 2019	BUY	$9.74 - $14.5 $194,011 - $288,825	19,919 Added 94.55%	40,986 $439,000
Q3 2018 Dec 21, 2021	BUY	$10.88 - $14.95 $26,666 - $36,642	2,451 Added 13.17%	21,067 $293,000
Q3 2018 Nov 14, 2018	BUY	$10.88 - $14.95 $92,860 - $127,598	8,535 Added 84.66%	18,616 $259,000
Q2 2018 Apr 21, 2020	BUY	$12.24 - $17.05 $20,098 - $27,996	1,642 Added 19.46%	10,081 $124,000
Q2 2018 Aug 14, 2018	BUY	$12.24 - $17.05 $103,293 - $143,884	8,439 New	8,439 $102,000

Others Institutions Holding RCUS

# of Institutions

201

Shares Held

51.7M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.11B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account